These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 7617005)
21. [Drugs, agranulocytosis and aplastic anemia]. Lunde PK; Baksaas I Tidsskr Nor Laegeforen; 1986 Nov; 106(31):2639-41. PubMed ID: 3810581 [No Abstract] [Full Text] [Related]
22. Aplastic anemia associated with ticlopidine. Shapiro CM; Walk D Neurology; 1996 Jul; 47(1):300. PubMed ID: 8710103 [No Abstract] [Full Text] [Related]
23. [Agranulocytosis and aplastic anemia induced by drugs]. Laporte JR Med Clin (Barc); 1987 Apr; 88(13):555-8. PubMed ID: 3295412 [No Abstract] [Full Text] [Related]
24. Severe normochrome and normocytic anemia after 19 months on ticlopidine. Finsterer J J Neuropsychiatry Clin Neurosci; 1999; 11(1):118-9. PubMed ID: 9990572 [No Abstract] [Full Text] [Related]
25. The design of a study of the drug etiology of agranulocytosis and aplastic anemia. A report from the International Agranulocytosis and Aplastic Anemia Study. Eur J Clin Pharmacol; 1983; 24(6):833-6. PubMed ID: 6884419 [No Abstract] [Full Text] [Related]
26. Ticlopidine-induced myelosuppression spontaneously remitted after five years: a possible link with amlodipine coadministration. Girtovitis F; Ntaios G; Baltatzi M; Kaiafa G; Ioannidis G; Chatzinikolaou A; Hatzitolios A; Papadopoulos A Intern Med J; 2009 May; 39(5):342-3. PubMed ID: 19545246 [No Abstract] [Full Text] [Related]
27. Aplastic anemia with ticlopidine therapy in two Chinese patients. Dunn P Ann Pharmacother; 1996 May; 30(5):547. PubMed ID: 8740343 [No Abstract] [Full Text] [Related]
28. Agranulocytosis and bone marrow aplasia induced by second-line drugs for rheumatoid arthritis. Treatment with granulocyte colony-stimulating factor. Sayag-Boukris V; Ziza JM; Brice P; Wechsler B Rev Rhum Engl Ed; 1997 Jan; 64(1):66. PubMed ID: 9051866 [No Abstract] [Full Text] [Related]
29. A randomized trial comparing ticlopidine hydrochloride with indobufen for the prevention of stroke in high-risk patients (TISS Study). Ticlopidine Indobufen Stroke Study. Bergamasco B; Benna P; Carolei A; Rasura M; Rudelli G; Fieschi C Funct Neurol; 1997; 12(1):33-43. PubMed ID: 9127122 [TBL] [Abstract][Full Text] [Related]
30. Ticlopidine and severe aplastic anemia. Rodriguez JN; Fernandez-Jurado A; Dieguez JC; Amian A; Prados D Am J Hematol; 1994 Dec; 47(4):332. PubMed ID: 7977309 [No Abstract] [Full Text] [Related]
31. [Hemopathies caused by drugs in children: aplastic anemia, agranulocytosis, megaloblastic anemia]. Masera G; Baronciani D; Conti A; Jankovic M; Uderzo C Minerva Pediatr; 1978 Sep; 30(18):1463-72. PubMed ID: 703709 [No Abstract] [Full Text] [Related]
32. [Bone marrow aplasia associated with ticlopidine treatment in a patient with idiopathic hypothyroidism]. Pioda GB; Del Favero A; Rambotti P Clin Ter; 1989 Sep; 130(6):337-40. PubMed ID: 2530035 [TBL] [Abstract][Full Text] [Related]